{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T09:14:25Z","timestamp":1792660465740,"version":"4.5.0"},"reference-count":57,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T00:00:00Z","timestamp":1360800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Dermatology"],"published-print":{"date-parts":[[2013,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>To systematically review the literature evaluating efficacy and adverse events of propranolol treatment for infantile hemangiomas, we searched the <jats:styled-content style=\"fixed-case\">MEDLINE<\/jats:styled-content> and Cochrane databases for all studies examining the response of infantile hemangiomas (IHs) to propranolol published between June 12, 2008, and June 15, 2012. Forty\u2010one studies with 1,264 patients were included; 74% of patients were female and approximately 30% had received other treatments before propranolol. Propranolol was initiated at a mean age of 6.6\u00a0months at a mean dose of 2.1\u00a0mg\/kg\/day and for a mean treatment duration of 6.4\u00a0months. The response rate for patients with IHs treated with propranolol was 98% (range 82%\u2013100%), with response rate defined as any improvement with propranolol. Treatment response rates were comparable for studies evaluating IHs at specific sites, such as periorbital IHs. Studies that followed patients after treatment completion reported IH rebound growth in 17% of patients. There were 371 adverse events reported in 1,189 patients. The most common adverse events were changes in sleep (<jats:italic>n<\/jats:italic>\u00a0=\u00a0136) and acrocyanosis (<jats:italic>n\u00a0<\/jats:italic>=\u00a061). Serious adverse events were rare, with reports of symptomatic hypotension in five patients, hypoglycemia in four, and symptomatic bradycardia in one. This systematic review of 1,264 patients treated with propranolol for IHs showed a high rate of efficacy and a low rate of serious adverse events.<\/jats:p>","DOI":"10.1111\/pde.12089","type":"journal-article","created":{"date-parts":[[2013,2,14]],"date-time":"2013-02-14T07:45:38Z","timestamp":1360827938000},"page":"182-191","source":"Crossref","is-referenced-by-count":214,"title":["Propranolol and Infantile Hemangiomas Four Years Later: A Systematic Review"],"prefix":"10.1111","volume":"30","author":[{"given":"Ann L.","family":"Marqueling","sequence":"first","affiliation":[{"name":"Department of Dermatology University of California at San Francisco San Francisco California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash","family":"Oza","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California at San Francisco San Francisco California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilona J.","family":"Frieden","sequence":"additional","affiliation":[{"name":"Department of Dermatology University of California at San Francisco San Francisco California"},{"name":"Department of Pediatrics University of California at San Francisco San Francisco California"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine B.","family":"Puttgen","sequence":"additional","affiliation":[{"name":"Department of Dermatology School of Medicine Johns Hopkins University Baltimore Maryland"},{"name":"Department of Pediatrics School of Medicine Johns Hopkins University Baltimore Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2013,2,14]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3016.2011.01214.x"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2008.00626.x"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2012.02.052"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0708819"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2010-0029"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2010.02344.x"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2010.05.002"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2010.192245"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.10.031"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.40"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2011.233"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S24141"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2010.07.025"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.21358"},{"key":"e_1_2_7_16_1","first-page":"341","article-title":"Use of propranolol in infantile haemangioma among Chinese children","volume":"16","author":"Chik KK","year":"2010","journal-title":"Hong Kong Med J"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01551.x"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1001\/archoto.2011.55"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijporl.2012.01.020"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1684\/ejd.2011.1372"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2011.203"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpedsurg.2011.10.058"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1177\/120347541201600508"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2007.28"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-2767"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2010.01379.x"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1290\/1071-2690(2002)038<0298:BBIAIC>2.0.CO;2"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s002280050604"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/0002-8703(85)90695-7"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.137.9.1208"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2011-3683"},{"key":"e_1_2_7_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01664.x"},{"key":"e_1_2_7_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01685.x"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0b013e31823bfffb"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525\u20101470.2012.01723.x"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365\u20102230.2012.04425.x"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01345.x"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1177\/120347541201600306"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ad.2011.02.009"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/0009922811405517"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1002\/lary.20807"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1097\/SAP.0b013e31821ee3a5"},{"key":"e_1_2_7_43_1","first-page":"137","article-title":"Preliminary results of propranolol treatment for patients with infantile hemangioma","volume":"53","author":"Corapcio\u011flu F","year":"2011","journal-title":"Turk J Pediatr"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.06.048"},{"key":"e_1_2_7_45_1","first-page":"450","article-title":"Propranolol for infantile hemangiomas: a preliminary report on efficacy and safety in very low birth weight infants","volume":"52","author":"Erbay A","year":"2010","journal-title":"Turk J Pediatr"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.4103\/0971-9261.86892"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2011.01.025"},{"key":"e_1_2_7_48_1","first-page":"A3482","article-title":"[Treatment of haemangiomas of infancy with propranolol; good results, few side effects]","volume":"155","author":"Hermans DJJ","year":"2011","journal-title":"Ned Tijdschr Geneeskd"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2010.07.009"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pedneo.2012.01.010"},{"key":"e_1_2_7_51_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09597.x"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04314.x"},{"key":"e_1_2_7_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.12.040"},{"key":"e_1_2_7_54_1","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2008-3458"},{"key":"e_1_2_7_55_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-010-1324-2"},{"key":"e_1_2_7_56_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1470.2011.01569.x"},{"key":"e_1_2_7_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bjps.2010.06.010"},{"key":"e_1_2_7_58_1","doi-asserted-by":"publisher","DOI":"10.1097\/PRS.0b013e318245e739"}],"container-title":["Pediatric Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fpde.12089","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/pde.12089","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:24:36Z","timestamp":1697261076000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/pde.12089"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,14]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,3]]}},"alternative-id":["10.1111\/pde.12089"],"URL":"https:\/\/doi.org\/10.1111\/pde.12089","archive":["Portico"],"relation":{},"ISSN":["0736-8046","1525-1470"],"issn-type":[{"value":"0736-8046","type":"print"},{"value":"1525-1470","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,14]]}}}